Arkolith/Insider Trading/RXST/Form 4

Wilterding Mark

Chief Financial OfficerRxSight, Inc. (RXST) · full profile →Form 4 · filed Jan 30, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 12, 2026Grant(A)259K—$0259K
Jan 12, 2026Grant(A)164K—$0164K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-031826) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML